Medicine Prices in Asia–Pacific Countries

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.
Original languageEnglish
Title of host publicationMedicine Price Surveys, Analyses and Comparisons
Subtitle of host publicationEvidence and Methodology Guidance
EditorsSabine Vogler
PublisherElsevier
Chapter2.3
Pages45-60
Number of pages16
Edition1st
ISBN (Electronic)9780128132128
ISBN (Print)9780128131664
DOIs
Publication statusPublished - 2019

Fingerprint

Medicine
Cost Savings
Hepatitis C
Costs and Cost Analysis
Health
Neoplasms

Cite this

Babar, Z-U-D., Hussain, R., & Hasan, S. S. (2019). Medicine Prices in Asia–Pacific Countries. In S. Vogler (Ed.), Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance (1st ed., pp. 45-60). Elsevier. https://doi.org/10.1016/B978-0-12-813166-4.00005-X
Babar, Zaheer-Ud-Din ; Hussain, Rabia ; Hasan, Syed Shahzad. / Medicine Prices in Asia–Pacific Countries. Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance. editor / Sabine Vogler. 1st. ed. Elsevier, 2019. pp. 45-60
@inbook{1429b5bb621b4844beda59bffe3c681f,
title = "Medicine Prices in Asia–Pacific Countries",
abstract = "The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.",
keywords = "Asia–Pacific, High-cost medicines, Prices, Generic medicines, Cancer, CNS",
author = "Zaheer-Ud-Din Babar and Rabia Hussain and Hasan, {Syed Shahzad}",
year = "2019",
doi = "10.1016/B978-0-12-813166-4.00005-X",
language = "English",
isbn = "9780128131664",
pages = "45--60",
editor = "Sabine Vogler",
booktitle = "Medicine Price Surveys, Analyses and Comparisons",
publisher = "Elsevier",
edition = "1st",

}

Babar, Z-U-D, Hussain, R & Hasan, SS 2019, Medicine Prices in Asia–Pacific Countries. in S Vogler (ed.), Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance. 1st edn, Elsevier, pp. 45-60. https://doi.org/10.1016/B978-0-12-813166-4.00005-X

Medicine Prices in Asia–Pacific Countries. / Babar, Zaheer-Ud-Din; Hussain, Rabia; Hasan, Syed Shahzad.

Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance. ed. / Sabine Vogler. 1st. ed. Elsevier, 2019. p. 45-60.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Medicine Prices in Asia–Pacific Countries

AU - Babar, Zaheer-Ud-Din

AU - Hussain, Rabia

AU - Hasan, Syed Shahzad

PY - 2019

Y1 - 2019

N2 - The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.

AB - The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.

KW - Asia–Pacific

KW - High-cost medicines

KW - Prices

KW - Generic medicines

KW - Cancer

KW - CNS

UR - https://www.elsevier.com/books/medicine-price-surveys-analyses-and-comparisons/vogler/978-0-12-813166-4

U2 - 10.1016/B978-0-12-813166-4.00005-X

DO - 10.1016/B978-0-12-813166-4.00005-X

M3 - Chapter

SN - 9780128131664

SP - 45

EP - 60

BT - Medicine Price Surveys, Analyses and Comparisons

A2 - Vogler, Sabine

PB - Elsevier

ER -

Babar Z-U-D, Hussain R, Hasan SS. Medicine Prices in Asia–Pacific Countries. In Vogler S, editor, Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance. 1st ed. Elsevier. 2019. p. 45-60 https://doi.org/10.1016/B978-0-12-813166-4.00005-X